Acorda Therapeutics
ACOR
#11271
Rank
A$1.19 M
Marketcap
A$0.96
Share price
0.00%
Change (1 day)
-95.84%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -A$0.41 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2023 the company made an earning of -A$0.39 Billion a decrease over its 2022 earnings that were of -A$7.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.41 Billion3.86%
2023 -A$0.39 Billion4848.63%
2022 -A$7.8 Million-93.25%
2021 -A$0.12 Billion2.52%
2020 -A$0.12 Billion-69.45%
2019 -A$0.37 Billion-700.62%
2018 A$61.33 M-118.02%
2017 -A$0.35 Billion805.99%
2016 -A$37.58 Million-173.88%
2015 A$50.85 M-6.58%
2014 A$54.43 M20.19%
2013 A$45.29 M18.7%
2012 A$38.15 M-26.54%
2011 A$51.94 M
2009 -A$0.12 Billion10.65%
2008 -A$0.11 Billion86.17%
2007 -A$57.58 Million68.1%
2006 -A$34.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-A$0.2 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$44.77 M-111.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-A$0.12 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
A$63.73 M-116.07%๐Ÿ‡บ๐Ÿ‡ธ USA